Form 4: Guardant Health Director Sells 100 Shares of Common Stock
SEC Form 4 Filing
Meghan V. Joyce, a director at Guardant Health, sold 100 shares of common stock on December 2, 2024.
Summary
- Meghan V. Joyce, a director at Guardant Health, Inc., sold 100 shares of the company's common stock.
- The transaction occurred on December 2, 2024.
- The sale price was $35.9 per share.
- Following the transaction, Ms. Joyce directly owns 7,548 shares of Guardant Health common stock.
Sentiment
Score: 5
Explanation: The document is a neutral disclosure of a routine stock sale by a director. It doesn't indicate any positive or negative sentiment about the company's performance.
Industry Context
This is a routine Form 4 filing, which is common for corporate insiders who trade company stock. It provides transparency into the trading activities of company directors.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
- The sale of 100 shares by a director is a relatively small transaction and not unusual.
Stakeholder Impact
- The sale of 100 shares by a director is unlikely to have a significant impact on stakeholders.
Key Dates
| Date | Description |
|---|---|
| 12/02/2024 | Date of the stock sale transaction. |
| 12/03/2024 | Date the Form 4 was signed. |
Keywords
Guardant Health, stock sale, insider trading, Form 4, director, equity securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.